Polymer nanoparticles containing tumor lysates as antigen delivery vehicles for dendritic cell-based antitumor immunotherapy.
about
Improving the clinical impact of biomaterials in cancer immunotherapy.The era of bioengineering: how will this affect the next generation of cancer immunotherapy?Targeting human dendritic cells via DEC-205 using PLGA nanoparticles leads to enhanced cross-presentation of a melanoma-associated antigenA therapeutic microparticle-based tumor lysate vaccine reduces spontaneous metastases in murine breast cancer.In Vivo Modulation of Dendritic Cells by Engineered Materials: Towards New Cancer Vaccines.Identification of BALB/c Immune Markers Correlated with a Partial Protection to Leishmania infantum after Vaccination with a Rationally Designed Multi-epitope Cysteine Protease A Peptide-Based Nanovaccine.Nanoparticle-Based Manipulation of Antigen-Presenting Cells for Cancer Immunotherapy.Applications of polymeric adjuvants in studying autoimmune responses and vaccination against infectious diseases.Enhancement of anti-tumor effect of particulate vaccine delivery system by 'bacteriomimetic' CpG functionalization of poly-lactic-co-glycolic acid nanoparticlesNanocarrier-based immunotherapy in cancer management and research.Nanoparticle-based vaccine delivery for cancer immunotherapy.Enhanced stimulation of anti-breast cancer T cells responses by dendritic cells loaded with poly lactic-co-glycolic acid (PLGA) nanoparticle encapsulated tumor antigens.Tumor lysate-loaded biodegradable microparticles as cancer vaccines.Engineered dendritic cells for gastrointestinal tumor immunotherapy: opportunities in translational research.Nanoengineered strategies to optimize dendritic cells for gastrointestinal tumor immunotherapy: from biology to translational medicine.Nanomedicine and cancer immunotherapy - targeting immunosuppressive cells.Anticancer and immunostimulatory role of encapsulated tumor antigen containing cobalt oxide nanoparticles.Assessment of tumor antigen-loaded solid lipid nanoparticles as an efficient delivery system for dendritic cell engineering.Effect of preparation conditions on the size and encapsulation properties of mPEG-PLGA nanoparticles simultaneously loaded with vincristine sulfate and curcumin.A simple, clinically relevant therapeutic vaccine shows long-term protection in an aggressive, delayed-treatment B lymphoma model.Effect of silver nanoparticles and hydroxyproline, administered in ovo, on the development of blood vessels and cartilage collagen structure in chicken embryos.Controlled release of antigen and Toll-like receptor ligands from PLGA nanoparticles enhances immunogenicity.Nanoparticles: augmenting tumor antigen presentation for vaccine and immunotherapy treatments of cancer.Rare-Earth Nanoparticles with Enhanced Upconversion Emission and Suppressed Rare-Earth-Ion Leakage
P2860
Q26766267-99EFBA9C-EF6C-4334-9318-B2ADC38D2315Q33815087-38B1E96B-A913-48FD-A7BE-011D709E7D6DQ34532116-40463156-15BB-45AC-8CB5-7833449C5424Q35318315-971F0DB3-AD5C-4895-8ECF-0445AD0235EAQ35573167-22FE5050-4539-4F7C-9058-2BF611ACA2A9Q36257481-A83165AF-752B-4D25-9558-83491FF9F5FCQ36269694-EDF74163-D5EC-4849-940A-05A46FBC8127Q36591050-4298BF43-7878-4688-B70C-229E6C1DA1A4Q36822999-98C83044-84CB-47DF-A37E-313EC7482DACQ37031671-158A5FDF-03D0-47DE-B2A5-467F669085BBQ37279161-ADE3ED87-B9DE-48DA-8CDA-1492C75C0BB8Q37367163-64457CCF-278F-401E-87B5-B09CC65F9742Q37670779-9AC4C1B3-B322-4BD4-BD32-8572B3CC83F0Q38051671-66A79987-A847-4A0F-A4B0-1EE18C9F3A11Q38269126-F1DE5D70-5734-4F94-9AF1-62F34FAAC5FAQ38603362-1D22B224-631C-44BE-A02D-0AC3E3A4CE3CQ39094835-0D2BCC6E-5E04-4643-8E23-54AA72AA802FQ43425908-49E26234-B78B-41C7-B5BB-5A31AE926EC9Q47305202-7C2DD900-16AE-4752-9379-3179F28D94E1Q47357871-7BA41878-C962-48A7-91BB-6511C7B04746Q50612685-B7547532-A52A-4B3E-91BA-460EE3D0DEB1Q51144432-0061623B-525E-4A5B-B641-F935DA2B3C70Q52746279-6FABB172-DE6F-4D1B-9C55-E1E83C58F275Q58410034-0A089613-DB5E-4D4E-90BC-C9E09DD8E65B
P2860
Polymer nanoparticles containing tumor lysates as antigen delivery vehicles for dendritic cell-based antitumor immunotherapy.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Polymer nanoparticles containi ...... based antitumor immunotherapy.
@ast
Polymer nanoparticles containi ...... based antitumor immunotherapy.
@en
Polymer nanoparticles containi ...... based antitumor immunotherapy.
@nl
type
label
Polymer nanoparticles containi ...... based antitumor immunotherapy.
@ast
Polymer nanoparticles containi ...... based antitumor immunotherapy.
@en
Polymer nanoparticles containi ...... based antitumor immunotherapy.
@nl
prefLabel
Polymer nanoparticles containi ...... based antitumor immunotherapy.
@ast
Polymer nanoparticles containi ...... based antitumor immunotherapy.
@en
Polymer nanoparticles containi ...... based antitumor immunotherapy.
@nl
P2093
P2860
P1476
Polymer nanoparticles containi ...... based antitumor immunotherapy.
@en
P2093
Clarence T Sasaki
Douglas J Hanlon
Jennifer K Saucier-Sawyer
Martin A Birchall
Richard L Edelson
Shashi Prasad
Virginia Cody
W Mark Saltzman
P2860
P356
10.1016/J.NANO.2010.07.002
P577
2010-08-06T00:00:00Z